newdrugapprovals.org
Biogen’s multiple sclerosis drug Tecfidera obtains EU approval
US-based Biogen Idec has received approval from the European Commission (EC) for its Tecfidera (dimethyl fumarate) as a first-line oral treatment for people with relapsing-remitting multiple sclero…